These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 20718496

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide.
    Herrera E, Gomara MJ, Mazzini S, Ragg E, Haro I.
    J Phys Chem B; 2009 May 21; 113(20):7383-91. PubMed ID: 19402654
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthetic peptides derived from an N-terminal domain of the E2 protein of GB virus C in the study of GBV-C/HIV-1 co-infection.
    Fernández L, Chan WC, Egido M, Gómara MJ, Haro I.
    J Pept Sci; 2012 May 21; 18(5):326-35. PubMed ID: 22438139
    [Abstract] [Full Text] [Related]

  • 6. HIV-1 gp41: mediator of fusion and target for inhibition.
    Weiss CD.
    AIDS Rev; 2003 May 21; 5(4):214-21. PubMed ID: 15012000
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
    Konopka K, Pretzer E, Düzgünes N.
    Biochem Biophys Res Commun; 1995 Mar 08; 208(1):75-81. PubMed ID: 7887968
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of HIV entry inhibitors targeted to the coiled-coil regions of gp41.
    Jiang S, Debnath AK.
    Biochem Biophys Res Commun; 2000 Mar 24; 269(3):641-6. PubMed ID: 10720469
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R, Decroly E, Kieny MP, Fenouillet E.
    Virology; 2000 Jul 20; 273(1):169-77. PubMed ID: 10891419
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS, Rawat SS, Jiang S, Blumenthal R.
    Biochemistry; 2003 Dec 09; 42(48):14150-8. PubMed ID: 14640682
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity.
    Jiang S, Debnath AK.
    Biochem Biophys Res Commun; 2000 Apr 02; 270(1):153-7. PubMed ID: 10733920
    [Abstract] [Full Text] [Related]

  • 17. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
    Maerz AL, Drummer HE, Wilson KA, Poumbourios P.
    J Virol; 2001 Jul 02; 75(14):6635-44. PubMed ID: 11413331
    [Abstract] [Full Text] [Related]

  • 18. Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41.
    Gallo SA, Clore GM, Louis JM, Bewley CA, Blumenthal R.
    Biochemistry; 2004 Jun 29; 43(25):8230-3. PubMed ID: 15209519
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments.
    Imai M, Baranyi L, Okada N, Okada H.
    Biochem Biophys Res Commun; 2007 Feb 23; 353(4):851-6. PubMed ID: 17210123
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.